Skip to main content
Poster
Diabetic foot ulceration is a complex pathology that even after healing may result in recurrence for 75% of the patients within five years. Various methods to augment the healed area and redistribute…
Poster
The authors recently described the safety and performance of a novel advanced wound care matrix (AWCM) in an IRB-approved retrospective study with 10 diabetic foot ulcer patients. This matrix…
Poster
Introduction: Diabetic foot ulcers (DFUs) are a significant burden on the worldwide health-care system. These chronic lower extremity wounds are often refractory to standard of care and can result in…
Poster
Introduction: Advanced tissue matrices have shown promise for treating diabetic wounds and other soft tissue defects. Recent advancements in technology have led to the introduction of a novel…
Poster
Introduction: Venous leg ulcerations (VLUs) frequently represent a significant clinical challenge. Dehydrated human amnion and chorion allografts have shown great promise in the treatment of…
Poster
Introduction: Non-healing diabetic foot ulcers (DFUs) frequently represent a significant clinical challenge. Cryopreserved viable human amnion membrane (vHAMA) has shown great promise in the…
Poster
Background: Venous leg ulcerations (VLUs) frequently represent a significant clinical challenge. Dehydrated human amnion and chorion allografts have shown great promise in the treatment of…
Poster
Background: Allogeneic grafts derived from amnion/chorion are known to be efficacious in healing chronic diabetic foot ulcerations (DFUs).  Aseptically processed grafts may have a benefit…
Poster
Background: Advanced Tissue Matrices have shown promise for treating diabetic wounds and other soft tissue defects. Recent advancements in technology have led to the introduction of a novel…
Poster
Background: The cancer analogy has proven effective for provisioning care to patients with diabetic foot ulcers (DFU). One potentially under-appreciated similarity between cancer and DFU is that…
Back to Top